174 related articles for article (PubMed ID: 7559191)
21. In vitro activity of rilopirox against fluconazole-susceptible and fluconazole-resistant Candida isolates from patients with HIV infection.
Nenoff P; Taneva E; Pfeil B; Oswald U; Haustein UF
Mycoses; 1999 Apr; 42(1-2):55-60. PubMed ID: 10394849
[TBL] [Abstract][Full Text] [Related]
22. Azole cross-resistance to ketoconazole, fluconazole, itraconazole and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidosis.
Müller FM; Weig M; Peter J; Walsh TJ
J Antimicrob Chemother; 2000 Aug; 46(2):338-40. PubMed ID: 10933673
[No Abstract] [Full Text] [Related]
23. [Evaluation of the E-test: comparison of E-test and microbroth dilution method in azole antifungal susceptibility test].
Komaki H; Tanaka Y; Yazawa K; Kadowaki K; Thomson KS; Mikami Y
Nihon Ishinkin Gakkai Zasshi; 1998; 39(1):27-31. PubMed ID: 9487005
[TBL] [Abstract][Full Text] [Related]
24. Oral Candida albicans isolates with reduced susceptibility to fluconazole in Swedish HIV-infected patients.
Chryssanthou E; Torssander J; Petrini B
Scand J Infect Dis; 1995; 27(4):391-5. PubMed ID: 8658076
[TBL] [Abstract][Full Text] [Related]
25. Unresponsive HIV-related oro-oesophageal candidosis--an evaluation of two new in-vitro azole susceptibility tests.
Cartledge JD; Midgley J; Petrou M; Shanson D; Gazzard BG
J Antimicrob Chemother; 1997 Oct; 40(4):517-23. PubMed ID: 9372421
[TBL] [Abstract][Full Text] [Related]
26. Fluconazole susceptibility of Candida isolates from oropharyngeal candidosis.
Dannaoui E; Lacoste V; Prat C; Piens MA
Mycoses; 1997 Nov; 40(7-8):279-82. PubMed ID: 9476510
[TBL] [Abstract][Full Text] [Related]
27. Fluconazole- and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities.
Le Guennec R; Reynes J; Mallié M; Pujol C; Janbon F; Bastide JM
J Clin Microbiol; 1995 Oct; 33(10):2732-7. PubMed ID: 8567915
[TBL] [Abstract][Full Text] [Related]
28. Response to fluconazole by 23 patients with human immunodeficiency virus infection and oral candidiasis: pharmacological and mycological factors.
Lacassin F; Damond F; Chochillon C; Longuet P; Lebras J; Vilde JL; Leport C
Antimicrob Agents Chemother; 1996 Aug; 40(8):1961-3. PubMed ID: 8843316
[TBL] [Abstract][Full Text] [Related]
29. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis.
Pfaller MA; Rhine-Chalberg J; Redding SW; Smith J; Farinacci G; Fothergill AW; Rinaldi MG
J Clin Microbiol; 1994 Jan; 32(1):59-64. PubMed ID: 7907345
[TBL] [Abstract][Full Text] [Related]
30. Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDS.
Ruhnke M; Schmidt-Westhausen A; Morschhäuser J
J Antimicrob Chemother; 2000 Aug; 46(2):291-5. PubMed ID: 10933656
[TBL] [Abstract][Full Text] [Related]
31. Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review.
White A; Goetz MB
Clin Infect Dis; 1994 Oct; 19(4):687-92. PubMed ID: 7803633
[TBL] [Abstract][Full Text] [Related]
32. Extracellular phospholipase production of oral Candida albicans isolates from smokers, diabetics, asthmatics, denture wearers and healthy individuals following brief exposure to polyene, echinocandin and azole antimycotics.
Ellepola AN; Samaranayake LP; Khan ZU
Braz J Microbiol; 2016; 47(4):911-916. PubMed ID: 27522928
[TBL] [Abstract][Full Text] [Related]
33. In vitro antifungal resistance of oral Candida albicans strains in non-AIDS patients.
Monteil RA; Madinier I; Le Fichoux Y
Oral Microbiol Immunol; 1997 Apr; 12(2):126-8. PubMed ID: 9227138
[TBL] [Abstract][Full Text] [Related]
34. Treatment of HIV-related fluconazole-resistant oral candidosis with D0870, a new triazole antifungal.
Cartledge JD; Denning DW; Dupont B; Clumeck N; De Wit S; Midgley J; Hawkins DA; Gazzard BG
AIDS; 1998 Mar; 12(4):411-6. PubMed ID: 9520171
[TBL] [Abstract][Full Text] [Related]
35. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
36. Isolation of fluconazole-resistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles.
Goff DA; Koletar SL; Buesching WJ; Barnishan J; Fass RJ
Clin Infect Dis; 1995 Jan; 20(1):77-83. PubMed ID: 7727675
[TBL] [Abstract][Full Text] [Related]
37. Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans.
Espinel-Ingroff A; Rodríguez-Tudela JL; Martínez-Suárez JV
J Clin Microbiol; 1995 Dec; 33(12):3154-8. PubMed ID: 8586692
[TBL] [Abstract][Full Text] [Related]
38. Change in fluconazole susceptibility patterns and genetic relationship among oral Candida albicans isolates.
Diaz-Guerra TM; Martinez-Suarez JV; Laguna F; Valencia E; Rodriguez-Tudela JL
AIDS; 1998 Sep; 12(13):1601-10. PubMed ID: 9764778
[TBL] [Abstract][Full Text] [Related]
39. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
Tapia C; González P; Pereira A; Pérez J; Noriega LM; Palavecino E
Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812
[TBL] [Abstract][Full Text] [Related]
40. Ketoconazole and itraconazole susceptibility of Candida albicans isolated from patients infected with HIV.
St-Germain G; Dion C; Espinel-Ingroff A; Ratelle J; de Repentigny L
J Antimicrob Chemother; 1995 Jul; 36(1):109-18. PubMed ID: 8537258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
